These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
398 related items for PubMed ID: 28641290
1. Long-Term Follow-Up of Choroidal Neovascularization due to Angioid Streaks with pro re nata Intravitreal Anti-VEGF Treatment. Giacomelli G, Finocchio L, Biagini I, Sodi A, Murro V, Introini U, Varano M, Bandello F, Menchini U. Ophthalmologica; 2017; 238(1-2):44-51. PubMed ID: 28641290 [Abstract] [Full Text] [Related]
2. INTRAVITREAL RANIBIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS: Four-Year Follow-up. Tilleul J, Mimoun G, Querques G, Puche N, Zerbib J, Lalloum F, Srour M, Souied EH. Retina; 2016 Mar; 36(3):483-91. PubMed ID: 26355947 [Abstract] [Full Text] [Related]
4. Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: a long-term follow-up study. Rosina C, Romano M, Cigada M, de Polo L, Staurenghi G, Bottoni F. Eur J Ophthalmol; 2015 Mar; 25(1):47-50. PubMed ID: 25044143 [Abstract] [Full Text] [Related]
5. Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study. Iacono P, Battaglia Parodi M, La Spina C, Bandello F. Am J Ophthalmol; 2016 May; 165():174-8. PubMed ID: 27013066 [Abstract] [Full Text] [Related]
6. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up. El Matri L, Kort F, Bouraoui R, Karim B, Chebil A, Chaker N. Acta Ophthalmol; 2011 Nov; 89(7):641-6. PubMed ID: 21155980 [Abstract] [Full Text] [Related]
7. Long-term follow-up of choroidal neovascularization in pathological myopia treated with intravitreal ranibizumab. Ladaique M, Dirani A, Ambresin A. Klin Monbl Augenheilkd; 2015 Apr; 232(4):542-7. PubMed ID: 25902117 [Abstract] [Full Text] [Related]
8. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. Lee JH, Lee SC, Kim SH, Koh HJ, Kim SS, Byeon SH, Lee CS. Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519 [Abstract] [Full Text] [Related]
9. Clinical course of choroidal neovascularization secondary to angioid streaks treated with intravitreal bevacizumab. Teixeira A, Mattos T, Velletri R, Teixeira R, Freire J, Moares N, Bonomo PP. Ophthalmic Surg Lasers Imaging; 2010 Aug; 41(5):546-9. PubMed ID: 20795575 [Abstract] [Full Text] [Related]
10. Intravitreal ranibizumab for choroidal neovascularization in angioid streaks. Mimoun G, Tilleul J, Leys A, Coscas G, Soubrane G, Souied EH. Am J Ophthalmol; 2010 Nov; 150(5):692-700.e1. PubMed ID: 20719301 [Abstract] [Full Text] [Related]
11. PSEUDOXANTHOMA ELASTICUM: SUCCESSFUL LONG-TERM MANAGEMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO ANGIOID STREAKS WITH PRO RE NATA INTRAVITREAL BEVACIZUMAB INJECTIONS. Kim J, Dalziel D. Retin Cases Brief Rep; 2021 May 01; 15(3):246-250. PubMed ID: 30048402 [Abstract] [Full Text] [Related]
12. Switching from ranibizumab to aflibercept in choroidal neovascularization secondary to angioid streaks. Sekfali R, Mimoun G, Cohen SY, Querques G, Bandello F, Sacconi R, Souied EH, Capuano V. Eur J Ophthalmol; 2020 May 01; 30(3):550-556. PubMed ID: 30880436 [Abstract] [Full Text] [Related]
13. Intravitreal Bevacizumab for Choroidal Neovascularization Associated with Angioid Streaks: Long-term Results. Lekha T, Prasad HN, Sarwate RN, Patel M, Karthikeyan S. Middle East Afr J Ophthalmol; 2017 May 01; 24(3):136-142. PubMed ID: 29279654 [Abstract] [Full Text] [Related]
14. INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANE DUE TO ANGIOID STREAKS. Alagöz C, Alagöz N, Özkaya A, Çelik U, Turan MF, Yazici AT, Çekiç O, Demirok A. Retina; 2015 Oct 01; 35(10):2001-10. PubMed ID: 25996427 [Abstract] [Full Text] [Related]
15. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION. Iacono P, Battaglia Parodi M, Selvi F, Parravano MC, Chiaravalloti A, Varano M, Bandello F. Retina; 2017 Oct 01; 37(10):1931-1941. PubMed ID: 28033235 [Abstract] [Full Text] [Related]
16. Intravitreal bevacizumab for nonsubfoveal choroidal neovascularization associated with angioid streaks. Battaglia Parodi M, Iacono P, La Spina C, Berchicci L, Scotti F, Leys A, Introini U, Bandello F. Am J Ophthalmol; 2014 Feb 01; 157(2):374-377.e2. PubMed ID: 24211865 [Abstract] [Full Text] [Related]
17. Long-term results of intravitreal bevacizumab injection for choroidal neovascularization secondary to angioid streaks. Sawa M, Gomi F, Tsujikawa M, Sakaguchi H, Tano Y. Am J Ophthalmol; 2009 Oct 01; 148(4):584-590.e2. PubMed ID: 19541288 [Abstract] [Full Text] [Related]
18. Management of CNV in angioid streaks by intravitreal use of specific anti-VEGF165 Aptamer (pegaptanib sodium): long-term results. Cekiç O, Göçmez E, Kocabora MS. Curr Eye Res; 2011 May 01; 36(5):492-5. PubMed ID: 21501082 [Abstract] [Full Text] [Related]
19. Inflammatory choroidal neovascularization in Indian eyes: Etiology, clinical features, and outcomes to anti-vascular endothelial growth factor. Roy R, Saurabh K, Bansal A, Kumar A, Majumdar AK, Paul SS. Indian J Ophthalmol; 2017 Apr 01; 65(4):295-300. PubMed ID: 28513493 [Abstract] [Full Text] [Related]
20. Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum. Battaglia Parodi M, Romano F, Marchese A, Arrigo A, Llorenç V, Cicinelli MV, Bandello F, Adán A. Graefes Arch Clin Exp Ophthalmol; 2019 Feb 01; 257(2):273-278. PubMed ID: 30470876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]